These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 35960887)

  • 1. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
    Frey MK; Ahsan MD; Bergeron H; Lin J; Li X; Fowlkes RK; Narayan P; Nitecki R; Rauh-Hain JA; Moss HA; Baltich Nelson B; Thomas C; Christos PJ; Hamilton JG; Chapman-Davis E; Cantillo E; Holcomb K; Kurian AW; Lipkin S; Offit K; Sharaf RN
    J Clin Oncol; 2022 Dec; 40(35):4129-4143. PubMed ID: 35960887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
    Ahsan MD; Levi SR; Webster EM; Bergeron H; Lin J; Narayan P; Nelson BB; Li X; Fowlkes RK; Brewer JT; Thomas C; Christos PJ; Chapman-Davis E; Cantillo E; Holcomb K; Sharaf RN; Frey MK
    PEC Innov; 2023 Dec; 2():100138. PubMed ID: 37214514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
    Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
    Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.
    Grutters LA; Christiaans I
    Fam Cancer; 2024 Jun; 23(2):155-164. PubMed ID: 38184510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
    Frey MK; Ahsan MD; Badiner N; Lin J; Narayan P; Nitecki R; Rauh-Hain JA; Moss H; Fowlkes RK; Thomas C; Bergeron H; Christos P; Levi SR; Blank SV; Holcomb K; Cantillo E; Sharaf RN; Lipkin S; Offit K; Chapman-Davis E
    Cancer; 2022 Dec; 128(24):4241-4250. PubMed ID: 36305018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.
    Cirino AL; Harris SL; Murad AM; Hansen B; Malinowski J; Natoli JL; Kelly MA; Christian S
    J Genet Couns; 2022 Dec; 31(6):1290-1305. PubMed ID: 35799446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
    Lin J; Sharaf RN; Saganty R; Ahsan D; Feit J; Khoury A; Bergeron H; Chapman-Davis E; Cantillo E; Holcomb K; Blank SV; Liu Y; Thomas C; Christos PJ; Wright DN; Lipkin S; Offit K; Frey MK
    Gynecol Oncol; 2021 Aug; 162(2):506-516. PubMed ID: 34023131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of Cascade Genetic Testing for Hereditary Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Ahsan MD; Chandler IR; Min S; Grant B; Primiano M; Greenwald J; Soussana TN; Baltich Nelson B; Thomas C; Chapman-Davis E; Sharaf RN; Frey MK
    Clin Obstet Gynecol; 2024 Dec; 67(4):702-710. PubMed ID: 39431491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.
    Braithwaite D; Emery J; Walter F; Prevost AT; Sutton S
    Fam Cancer; 2006; 5(1):61-75. PubMed ID: 16528610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.
    Pollard S; Kalloger S; Weymann D; Sun S; Nuk J; Schrader KA; Regier DA
    Health Expect; 2020 Aug; 23(4):884-892. PubMed ID: 32338425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
    Lahiri S; Pirzadeh-Miller S; Moriarty K; Kubiliun N
    Cancer Control; 2023; 30():10732748231175011. PubMed ID: 37161761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
    Baroutsou V; Underhill-Blazey ML; Appenzeller-Herzog C; Katapodi MC
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG Committee Opinion No. 727: Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2018 Jan; 131(1):e31-e34. PubMed ID: 29266077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.
    Caeser R; Chiang J; Tan ES; Tai ES; Ngeow J
    Fam Cancer; 2024 Jun; 23(2):133-140. PubMed ID: 38662262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary cancer syndromes, their testing and prevention.
    Foretová L
    Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.